Skip to content

Missouri Certificate of Need Laws

Certificate of Need Intelligence

Missouri

80/100

Highly Restrictive

Year Enacted

Services Regulated

National Rank

33 of 51

Top Systems

  • Major medical equipment (MRI

Reform Status

Partial Repeal Pending

Key Case

No major case law on record.

Certificate of Need Investigation

01Scope of Regulation

6 Services Held Hostage

  • Hospitals
  • Nursing Homes / Long-Term Care
  • Psychiatric Facilities
  • Imaging (MRI, CT, PET)
  • Rehabilitation Facilities
  • Major Medical Equipment
02The Application Process

The Permission Process

Missouri's CON law covers a broad range of healthcare services, requiring providers to obtain state approval for significant capital expenditures. This includes:

Missouri Health Facilities Review Committee

In a clear example of bureaucratic hurdles, the Missouri Health Facilities Review Committee unanimously denied a CON for an 18-bed residential care facility. The denial was not based on need, but on a technicality: the applicant had moved the proposed site by 1.5 miles after filing the initial letter of intent. This case highlights how CON regulations can stifle development over procedural minutiae rather than community benefit.

While full repeal has failed multiple times, a significant reform bill (SB 1268) was introduced in 2026 and is currently pending in the Senate Families, Seniors and Health Committee. If passed, the bill would eliminate CON review for new hospitals and major medical equipment. CON requirements would remain for other services like long-term care. The fight for a fully open market continues.

03Market Concentration

The Missouri Healthcare Cartel

Major medical equipment (MRI

Insurer Dominance

  • Top 3 Insurers
  • Our comprehensive overview of Certificate of Need laws across the United States.

CON laws often lead to consolidated markets, benefiting established players. In Missouri, the healthcare landscape is dominated by a few large systems, particularly in the St. Louis metropolitan area.

$81.4B in discounted drugs. Zero disclosure requirements.

05Legislative Environment

Partial Repeal Pending

Partial Repeal Pending

Data sourced from state agencies, Cicero Institute, and public records.

Last updated: April 2026